 phase II study weekly infusion high-dose fluorouracil leucovorin colorectal carcinoma Twenty-two patients advanced colorectal carcinoma study patients chemotherapy combination fluorouracil LV patients subcutaneous port insertion portable external infusion pumps outpatient treatment LV hours continuous infusion mean steady-state plasma concentration mumol/L range mumol/L dose previous phase maximum-tolerated dose MTD combination fixed dose LV treatment weekly Twenty-two patients total courses treatment Eleven instances grade toxicity diarrhea stomatitis hand/foot syndrome overall objective response untreated patients responders complete response CR lung liver metastatic sites median duration survival untreated patients months months patients results short-term infusional therapy LV patients advanced metastatic colorectal cancer acceptable toxicity equivalent superior survivability untreated patients alternative methods administration agents